A multidisciplinary judging panel will evaluate eligible Phase 1 submissions. The judging panel will include representation from patients and nephrologists, as well as experts across regulatory, commercialization, and technical domains. Judges will use the Phase 1 evaluation criteria to recommend up to eight Phase 1 winners from the pool of eligible submissions.


Judges will be announced at a later date.


Sign up for the KidneyX newsletter